Our PRKACA Break Apart FISH Probe is designed to detect PRKACA translocations. The probe comes labeled in green and orange, but can be customized to meet your needs.

Probe Details:

** This product is for in vitro and research use only. This product is not intended for diagnostic use.

Gene Summary

This gene encodes one of the catalytic subunits of protein kinase A, which exists as a tetrameric holoenzyme with two regulatory subunits and two catalytic subunits, in its inactive form. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits have been identified in humans. cAMP-dependent phosphorylation of proteins by protein kinase A is important to many cellular processes, including differentiation, proliferation, and apoptosis. Constitutive activation of this gene caused either by somatic mutations, or genomic duplications of regions that include this gene, have been associated with hyperplasias and adenomas of the adrenal cortex and are linked to corticotropin-independent Cushing's syndrome. Alternative splicing results in multiple transcript variants encoding different isoforms. Tissue-specific isoforms that differ at the N-terminus have been described, and these isoforms may differ in the post-translational modifications that occur at the N-terminus of some isoforms. [provided by RefSeq, Jan 2015]

Gene Details

Gene Symbol: PRKACA

Gene Name: Protein Kinase CAMP-activated Catalytic Subunit Alpha

Chromosome: CHR19: 14202506-14228559

Locus: 19p13.12

References

DNAJB1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma

A new DNAJB1-PRKACA fusion was recently discovered in fibrolamellar hepatocellular carcinoma (FHCC). This study sought to determine the specificity of this fusion for the disease through molecular and genetic analysis of six PRKACA-rearranged pancreatobiliary neoplasms. Empire Genomics’ PRKACA break apart FISH probe was used to detect PRKACA rearrangements in the tumors. Five cases were found to have DNAJB1-PRKACA fusions and one had ATP1B1-PRKACA fusion.